Prognostic and predictive value of androgen receptor expression in postmenopausal women with estrogen receptor-positive breast cancer: results from the Breast International Group Trial 1–98

被引：0
|
作者：
Kevin H. Kensler
Meredith M. Regan
Yujing J. Heng
Gabrielle M. Baker
Michael E. Pyle
Stuart J. Schnitt
Aditi Hazra
Roswitha Kammler
Beat Thürlimann
Marco Colleoni
Giuseppe Viale
Myles Brown
Rulla M. Tamimi
机构：
[1] Dana-Farber Cancer Institute,Department of Medical Oncology
[2] Harvard T.H. Chan School of Public Health,Department of Epidemiology
[3] Dana-Farber Cancer Institute,Department of Biostatistics and Computational Biology
[4] Harvard Medical School,Department of Pathology
[5] Beth Israel Deaconess Medical Center,Department of Pathology
[6] Brigham and Women’s Hospital,Department of Medicine
[7] Brigham and Women’s Hospital,Division of Medical Senology, IEO
[8] International Breast Cancer Study Group Coordinating Center,Department of Pathology, IEO, European Institute of Oncology IRCCS
[9] Central Pathology Office,Channing Division of Network Medicine
[10] Breast Center,undefined
[11] Cantonal Hospital,undefined
[12] St. Gallen and SAKK,undefined
[13] European Institute of Oncology IRCCS,undefined
[14] University of Milan,undefined
[15] Brigham and Women’s Hospital and Harvard Medical School,undefined
来源：
Breast Cancer Research | / 21卷
关键词：
Androgen receptor; Breast cancer; Letrozole; Tamoxifen; BIG 1–98;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Prognostic and predictive value of androgen receptor expression in postmenopausal women with estrogen receptor-positive breast cancer: results from the Breast International Group Trial 1-98
    Kensler, Kevin H.
    Regan, Meredith M.
    Heng, Yujing J.
    Baker, Gabrielle M.
    Pyle, Michael E.
    Schnitt, Stuart J.
    Hazra, Aditi
    Kammler, Roswitha
    Thurlimann, Beat
    Colleoni, Marco
    Viale, Giuseppe
    Brown, Myles
    Tamimi, Rulla M.
    BREAST CANCER RESEARCH, 2019, 21 (1)
  • [2] Prognostic value of androgen receptor expression in premenopausal women with estrogen receptor-positive breast cancer
    Yildirim, H. C.
    Uner, M.
    Yildiran, T.
    Guven, D. C.
    Yilmaz, F.
    Yasar, S.
    Evlendi, Y. N.
    Dizdar, O.
    Uner, A.
    Aksoy, S.
    ANNALS OF ONCOLOGY, 2022, 33 (08) : S1397 - S1397
  • [3] Expression of Androgen Receptor in Estrogen Receptor-positive Breast Cancer
    Agrawal, Anil
    Ziolkowski, Piotr
    Grzebieniak, Zygmunt
    Jelen, Michal
    Bobinski, Piotr
    Agrawal, Siddarth
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2016, 24 (08) : 550 - 555
  • [4] Differential impact of the expression of the androgen receptor by age in estrogen receptor-positive breast cancer
    Tokunaga, Eriko
    Hisamatsu, Yuichi
    Taketani, Kenji
    Yamashita, Nami
    Akiyoshi, Sayuri
    Okada, Satoko
    Tanaka, Kimihiro
    Saeki, Hiroshi
    Oki, Eiji
    Aishima, Shinichi
    Oda, Yoshinao
    Morita, Masaru
    Maehara, Yoshihiko
    CANCER MEDICINE, 2013, 2 (06): : 763 - 773
  • [5] The androgen receptor is a tumor suppressor in estrogen receptor-positive breast cancer
    Hickey, Theresa E.
    Selth, Luke A.
    Chia, Kee Ming
    Laven-Law, Geraldine
    Milioli, Heloisa H.
    Roden, Daniel
    Jindal, Shalini
    Hui, Mun
    Finlay-Schultz, Jessica
    Ebrahimie, Esmaeil
    Birrell, Stephen N.
    Stelloo, Suzan
    Iggo, Richard
    Alexandrou, Sarah
    Caldon, C. Elizabeth
    Abdel-Fatah, Tarek M.
    Ellis, Ian O.
    Zwart, Wilbert
    Palmieri, Carlo
    Sartorius, Carol A.
    Swarbrick, Alex
    Lim, Elgene
    Carroll, Jason S.
    Tilley, Wayne D.
    NATURE MEDICINE, 2021, 27 (02) : 310 - +
  • [6] Increased androgen receptor expression in estrogen receptor-positive/progesterone receptor-negative breast cancer
    Ximena García
    Andrés Elía
    Lucrecia Galizzi
    María May
    Eunice Spengler
    Paula Martínez Vázquez
    Javier Burruchaga
    Hugo Gass
    Claudia Lanari
    Caroline A. Lamb
    Breast Cancer Research and Treatment, 2020, 180 : 257 - 263
  • [7] Increased androgen receptor expression in estrogen receptor-positive/progesterone receptor-negative breast cancer
    Garcia, Ximena
    Elia, Andres
    Galizzi, Lucrecia
    May, Maria
    Spengler, Eunice
    Martinez Vazquez, Paula
    Burruchaga, Javier
    Gass, Hugo
    Lanari, Claudia
    Lamb, Caroline A.
    BREAST CANCER RESEARCH AND TREATMENT, 2020, 180 (01) : 257 - 263
  • [8] Prognostic and predictive value of low estrogen receptor expression in breast cancer
    Bouchard-Fortier, A.
    Provencher, L.
    Blanchette, C.
    Diorio, C.
    CURRENT ONCOLOGY, 2017, 24 (02) : E106 - E114
  • [9] Predictors of early relapse in postmenopausal women with hormone receptor-positive breast cancer in the BIG 1-98 trial
    Mauriac, L.
    Keshaviah, A.
    Debled, M.
    Mouridsen, H.
    Forbes, J. F.
    Thuerlimann, B.
    Paridaens, R.
    Monnier, A.
    Lang, I.
    Wardley, A.
    Nogaret, J.-M.
    Gelber, R. D.
    Castiglione-Gertsch, M.
    Price, K. N.
    Coates, A. S.
    Smith, I.
    Viale, G.
    Rabaglio, M.
    Zabaznyi, N.
    Goldhirsch, A.
    ANNALS OF ONCOLOGY, 2007, 18 (05) : 859 - 867
  • [10] Estrogen receptor β- an independent prognostic marker in estrogen receptor α and progesterone receptor-positive breast cancer?
    Maehle, Bjorn O.
    Collett, Karin
    Tretli, Steinar
    Akslen, Lars A.
    Grotmol, Tom
    APMIS, 2009, 117 (09) : 644 - 650
12345